MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
1.610
+0.035 (2.22%)
Mar 31, 2025, 3:43 PM EDT - Market open
MetaVia Market Cap
MetaVia has a market cap or net worth of $13.93 million as of March 31, 2025. Its market cap has decreased by -35.79% in one year.
Market Cap
13.93M
Enterprise Value
-2.27M
1-Year Change
-35.79%
Ranking
Category
Stock Price
$1.61
Market Cap Chart
Since August 5, 2016, MetaVia's market cap has decreased from $84.50M to $13.93M, a decrease of -83.51%. That is a compound annual growth rate of -18.81%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 13.60M | -22.29% |
| Dec 31, 2024 | 17.50M | -2.23% |
| Dec 29, 2023 | 17.90M | 280.85% |
| Dec 30, 2022 | 4.70M | -85.49% |
| Dec 31, 2021 | 32.40M | -62.41% |
| Dec 31, 2020 | 86.20M | 1,557.69% |
| Dec 31, 2019 | 5.20M | -55.17% |
| Dec 31, 2018 | 11.60M | -86.27% |
| Dec 29, 2017 | 84.50M | 16.23% |
| Dec 30, 2016 | 72.70M | -13.96% |
View and export this data all the way back to 2016.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |